Skip to Content
Merck
CN
  • Inhibition of SRC-mediated integrin signaling in bone marrow niche enhances hematopoietic stem cell function.

Inhibition of SRC-mediated integrin signaling in bone marrow niche enhances hematopoietic stem cell function.

iScience (2022-10-08)
Irene Mariam Roy, P V Anu, Samantha Zaunz, Srinu Reddi, Aravind M Giri, Rithika Saroj Sankar, Sarah Schouteden, Joerg Huelsken, Catherine M Verfaillie, Satish Khurana
ABSTRACT

Interaction with microenvironmental factors is crucial for the regulation of hematopoietic stem cell (HSC) function. Stroma derived factor (SDF)-1α supports HSCs in the quiescent state and is central to the homing of transplanted HSCs. Here, we show that integrin signaling regulates Sdf-1α expression transcriptionally. Systemic deletion of Periostin, an Integrin-αv ligand, showed increased expression of Sdf-1α in bone marrow (BM) niche. Pharmacological inhibition or CRISPR-Cas9-mediated deletion of SRC, resulted in a similar increase in the chemokine expression in vitro. Importantly, systemic SRC-inhibition led to increase in SDF-1α levels in BM plasma. This resulted in a robust increase (14.05 ± 1.22% to 29.11 ± 0.69%) in the homing efficiency of transplanted HSCs. In addition, we observed enhancement in the recovery of blood cell counts following radiation injury, indicating an enhanced hematopoietic function. These results establish a role of SRC-mediated integrin signaling in the transcriptional regulation of Sdf-1α. This mechanism could be harnessed further to improve the hematopoietic function.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-Fluorouracil, ≥99% (HPLC), powder
Sigma-Aldrich
DAPI, for nucleic acid staining